Elicio Therapeutics, Inc. (ELTX)

2.47 -0.08 (-3.14%) USD  |  NASDAQ  |  Sep 03, 12:16
More

Elicio Therapeutics Cash and Short Term Investments (Quarterly) : 23.48M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for ELTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 23.48M
March 31, 2026 14.95M
December 31, 2025 18.56M
September 30, 2025 20.61M
June 30, 2025 22.09M
March 31, 2025 19.03M
December 31, 2024 18.80M
September 30, 2024 27.33M
June 30, 2024 3.821M
March 31, 2024 12.52M
December 31, 2023 13.62M
September 30, 2023 16.51M
June 30, 2023 22.30M
March 31, 2023 29.22M
Date Value
December 31, 2022 7.797M
September 30, 2022 55.14M
June 30, 2022
March 31, 2022 73.00M
December 31, 2021 88.76M
September 30, 2021 102.74M
June 30, 2021 117.31M
March 31, 2021 130.46M
December 31, 2020 34.61M
September 30, 2020 14.11M
June 30, 2020
March 31, 2020
December 31, 2019 5.571M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Precigen, Inc. 38.21M
Agenus, Inc. 18.74M
Amgen, Inc. 13.99B
Anika Therapeutics, Inc. 38.41M
BioCryst Pharmaceuticals, Inc. 353.05M